Given that immune-mediated protection requires a fine balance between pro-inflammatory response that limits pathogen replication and anti-inflammatory response that prevents immunopathology, Bhlhe40 emerges as a key player in host immune responses to infections, autoimmune disorders and cancer [10,16]. The gene discussed is BHLHE40; the disease is cancer.